North America Optical Genome Mapping Market to Grow with a CAGR of 9.97% through 2030

Increase in the incidence of genetic disorders and increase in the demand for precision medicine is expected to drive the North America Optical Genome Mapping Market growth in the forecast period, 2026-2030

According to TechSci Research report, “North America Optical Genome Mapping Market – By Country, Competition, Forecast & Opportunities, 2030F”, the North America Optical Genome Mapping Market stood at USD 53.19 million in 2024 and is anticipated to grow with a CAGR of 9.97% in the forecast period, 2025-2030. The awareness among individuals regarding Optical Genome Mapping has led to favorable market conditions for the North America Optical Genome Mapping market.

The increasing focus on precision medicine represents another substantial catalyst for the optical genome mapping market. Precision medicine seeks to customize medical interventions for individual patients by considering their genetic characteristics. Optical genome mapping plays a crucial part in detecting genetic variances and structural irregularities, which are critical for determining the most efficient treatment methodologies. With healthcare providers and pharmaceutical firms progressively embracing precision medicine principles, the demand for optical genome mapping technologies is anticipated to experience a significant upswing.

Researchers and scientists are progressively adopting optical genome mapping technologies to investigate the structural variations and intricacies within genomes. This technology offers the capability for detailed DNA mapping, facilitating the identification of genetic mutations responsible for diseases and offering valuable insights into diverse biological processes. Given the pivotal role of genomics in personalized medicine and pharmaceutical development, the demand for optical genome mapping tools is experiencing steady growth.

Genome-wide association studies are instrumental in identifying genetic variations associated with complex diseases. While SNP (Single Nucleotide Polymorphism) arrays have been widely used in GWAS, they have limitations in detecting structural variations. Optical genome mapping supplements GWAS by enabling the identification of structural variations that may contribute to disease susceptibility.

Optical Genome Mapping excels at detecting structural variations in the genome, such as insertions, deletions, duplications, and translocations. This is crucial for understanding the genetic basis of diseases, including cancer, autism, and rare genetic disorders. Recent research has revealed the significance of structural variations in these conditions, making Optical Genome Mapping an invaluable tool for precise diagnosis and targeted treatments. In the field of oncology, Optical Genome Mapping has gained prominence for its ability to provide comprehensive insights into cancer genomes. Researchers and clinicians use it to identify genomic alterations, including large-scale chromosomal rearrangements and copy number variations, which play a critical role in cancer development and progression. This information guides treatment decisions, personalized therapies, and the development of novel cancer treatments. However, the High Initial Capital Investment may hinder market growth. Moreover, challenges related to Competition from Established Genomic Technologies and Data Analysis and Interpretation may pose obstacles to the Optical Genome Mapping market in the near future.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "North America Optical Genome Mapping Market”

The North America Optical Genome Mapping Market is segmented into product, application, end-user, regional distribution, and company.

Based on the category of Application, the genome assembly segment emerged as the dominant player in the North America market for Optical Genome Mapping in 2024. Genome assembly is a critical component of de novo genome sequencing, where the complete genome of an organism is sequenced without the need for a reference genome. Optical genome mapping is well-suited for de novo sequencing because it provides information about the organization and arrangement of DNA molecules. Researchers can use optical maps to guide the assembly of DNA fragments into a contiguous and accurate representation of the entire genome.

Optical genome mapping is particularly valuable when working with complex or non-model organisms, which may have large, repetitive genomes or structural complexities that challenge traditional sequencing methods. Researchers studying such organisms rely on optical genome mapping to obtain comprehensive genome assemblies that are difficult to achieve with short-read sequencing alone. This is especially relevant in areas like environmental genomics and biodiversity studies. Genome assembly is essential for comparative genomics, where researchers compare the genomes of different species to understand evolutionary relationships, gene function, and adaptations. Optical genome mapping aids in the accurate alignment and comparison of genomes, allowing researchers to identify structural differences, gene duplications, and other evolutionary events. This capability is crucial for a wide range of applications, including evolutionary biology and conservation genetics. These factors are expected to drive the growth of this segment..

Based on region, Canada market is poised to be the fastest-growing market, offering lucrative growth opportunities for Optical Genome Mapping players during the forecast period. Factors such as Canada has been steadily increasing its investments in genomics research, fostering collaborations between research institutions and industry partners. The Canadian genomics community is expanding its expertise in areas like structural genomics, metagenomics, and environmental genomics, where optical genome mapping technology is highly relevant. The Canadian government has demonstrated strong support for genomics research and technology adoption. Funding initiatives and research grants have encouraged the adoption of advanced genomics technologies like optical genome mapping. Canada's biotechnology and healthcare sectors are experiencing significant growth, providing a conducive environment for the adoption of genomics technologies in clinical and research settings.

Major companies operating in North America Optical Genome Mapping Market are:

·         Bionano Genomics, Inc., US

·         NabSys Inc., US

·         Nucleome Informatics Pvt Ltd

·         France Genomique

·         Praxis Genomics

·         PerkinElmer

·         OpGen, Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Advancements in Genomic Research and increasing Demand for Precision Medicine are key drivers of the Optical Genome Mapping market. In recent years, the growing emphasis on precision medicine, which tailor’s medical treatments based on individual genetic profiles, fuels the demand for optical genome mapping. Also, the growing consumer emphasis on preventative healthcare products has enhanced production and marketing efforts. To meet the demands of the market, manufacturers are increasingly incorporating cutting-edge technologies with high production efficiency. Rising consumer acceptance and continuous product innovation will further ensure the growth of the Optical Genome Mapping and supplements market in the coming years” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“North America Optical Genome Mapping Market Segmented By Product (Consumables, Instruments), By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, Others), By End-User (Research & Academic Institutions, Biotechnology & Pharmaceutical Companies, Clinical Laboratories, Others), By Country, Competition, Forecast & Opportunities 2020-2030F”, has evaluated the future growth potential of North America Optical Genome Mapping Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in North America Optical Genome Mapping Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com